Attitudes and eligibility of long-acting cabotegravir/rilpivirine treatment among youth living with HIV in a clinical and national cohort in Thailand: a cross-sectional study

Attitudes and eligibility of long-acting cabotegravir/rilpivirine treatment among youth living with HIV in a clinical and national cohort in Thailand: a cross-sectional study

Abstract Background Long-acting cabotegravir/rilpivirine (LA-CAB/RPV) is the only available approved injectable antiretroviral therapy (ART) for youth living with HIV (YLHIV). However, it is not yet available through the Thai National AIDS Program (NAP). This study assessed Thai YLHIV attitudes towa...

Full description

Saved in:
Bibliographic Details
Main Authors: Punnathorn Auaboonkanok, Wipaporn Natalie Songtaweesin, Suvaporn Anugulruengkitt, Chutima Saisaengjan, Jinnaphak Seesuksai, Sirinya Teeraananchai, Thanyawee Puthanakit
Format: Article
Language:English
Published: BMC 2025-07-01
Series:AIDS Research and Therapy
Subjects:
Adolescents
Long-acting antiretroviral therapy
Attitudes
Thailand
Online Access:https://doi.org/10.1186/s12981-025-00771-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12981-025-00771-3

Similar Items